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Abstract
Malaria in pregnancy is responsible for maternal anaemia, low-birth-weight babies and infant
deaths. Plasmodium falciparum infected erythrocytes are thought to cause placental pathology by
adhering to host receptors such as chondroitin sulphate A (CSA). CSA binding infected
erythrocytes also bind IgM natural antibodies from normal human serum, a process that may
facilitate placental adhesion or promote immune evasion. The parasite ligands that mediate
placental adhesion are thought to be members of the variant erythrocyte surface antigen family P.
falciparum erythrocyte membrane protein 1 (PfEMP1), encoded by the var genes. Two var gene
sub-families, var1CSA and var2CSA, have been identified as parasite CSA binding ligands and
are leading candidates for a vaccine to prevent pregnancy-associated malaria. We investigated
whether these two var gene subfamilies implicated in CSA binding are also the molecules
responsible for IgM natural antibody binding. By heterologous expression of domains in COS-7
cells, we found that both var1CSA and var2CSA PfEMP1 variants bound IgM, and in both cases
the binding region was a DBL epsilon domain occurring proximal to the membrane. None of the
domains from a control non-IgM-binding parasite (R29) bound IgM when expressed in COS-7
cells. These results show that PfEMP1 is a parasite ligand for non-immune IgM and are the first
demonstration of a specific adhesive function for PfEMP1 epsilon type domains.
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1. Introduction
During pregnancy-associated malaria, Plasmodium falciparum infected red blood cells are
sequestered in the placenta causing low-birth-weight, foetal and infant death and maternal
anaemia [1,2]. In the placenta, adhesion seems to occur between the host receptor
chondroitin sulphate A (CSA) and P. falciparum erythrocyte membrane protein one
(PfEMP1) [3-5]. PfEMP1 is a variant surface antigen encoded by the var gene family [6-8].
Every parasite contains 50–60 var genes in its genome, but only one is expressed at the
surface of the infected erythrocyte [7,9]. PfEMP1 molecules are composed of Duffy
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binding-like (DBL) domains classified into six types (alpha, beta, gamma, delta, epsilon and
type X) and cysteine-rich interdomain region domains (CIDR) classified into three types
(alpha, beta and gamma) [10,11]. Var genes differ from one other by the number and the
type of these domains. PfEMP1 is involved in adhesion of the infected erythrocyte to
various host receptors such as CD36 and ICAM-1 [12] during cytoadhesion to endothelium,
and complement receptor 1 (CR1) in the case of rosetting parasites [13]. The well-conserved
var1CSA and var2CSA sub-families are the main var gene candidates described so far to be
involved in pregnancy-associated malaria [3,14]. Heterologous expression experiments have
shown that the DBL3 gamma domain of var1CSA binds CSA [3], while several var2CSA
domains (DBL2X, DBL3X and DBL6ε) bound CSA [15].
Along with CSA adhesion, it has been shown that infected erythrocytes implicated in
placental adhesion are able to bind natural non-specific immunoglobulin M (IgM) antibodies
[16], a phenomenon previously observed on rosetting parasites [17,18]. PfEMP1 mediates
IgM binding on rosetting parasites [19] and may also be involved in IgM binding on CSA
binding parasites [16]. The function of these IgM natural antibodies on infected erythrocytes
is not understood. In the case of rosetting it has been suggested that IgM could act as a
bridge between infected and uninfected erythrocytes to strengthen the rosettes [18]. Another
hypothesis is that parasites allow binding of natural, non-specific IgM antibodies to block
the binding of specific immunoglobulins and therefore avoid clearance by the immune
system [17].
To further characterise CSA binding var gene candidates, we expressed each DBL and
CIDR domain of the PfEMP1 variants encoded by var1CSA and var2CSA to determine if
they bind IgM natural antibodies and to identify which domain or domains mediate IgM
binding.
2. Materials and methods
2.1. Parasite culture and var gene transcription
FCR3CSA parasites were cultured in complete RPMI as described previously [17].
Transcription of var2CSA in FCR3CSA was examined by northern blot as described
previously [20,21] using as a probe the exon 2 of the 3D7var2CSA allele. The blot was
hybridised and washed at low stringency (50 °C, 0.5X SSC wash).
2.2. Live cell IFA with FCR3CSA parasites grown in FCS
To determine if bovine IgM binds to FCR3CSA infected erythrocytes in a similar way to
human IgM, the parasites were cultured for four cycles in complete RPMI containing 10%
FCS instead of human serum. A live cell IFA was performed as described previously [16]
using a mouse monoclonal antibody to bovine IgM (Sigma, clone BM-23) at 1/1000
dilution, followed by a 1/500 dilution of highly cross-absorbed Alexa Fluor™ 488 labelled
goat anti-mouse IgG (Molecular Probes, Leiden, The Netherlands). Slides were viewed with
a Leica fluorescence microscope.
2.3. Cloning of var1CSA, var2CSA and R29var1 DBL and CIDR domains in the pRE4 vector
Each domain of var1CSA from the FCR3/IT P. falciparum strain (GenBank Accession no.
AJ133811) was amplified by polymerase chain reaction (PCR). For DBL1α, CIDRα,
DBL2β, DBL3γ and DBL7ε the primers used were as described by Buffet et al. [3]. The
amino-acid boundaries of the constructs amplified for the remaining domains were as
follows: DBL4ε (1610–2097), DBL5γ (2100–2389) and DBL6β (2533–2829). The
following domains were used for var2CSA from the FCR3/IT parasite strain (GenBank
Accession no. AAQ73926): DBLlX (13–437), DBL2X (410–897), IDR (inter-domain
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region: 862–1187), DBL3X (1166–1566), DBL4ε (1534–1968), DBL5ε (1939–2308) and
DBL6ε (2278–2600). As a negative control, the PfEMP1 domains from parasite clone R29,
a rosetting non-IgM binding parasite [17] expressing the R29var1 [13] variant were also
studied (GenBank Accession no. Y13402). The R29 constructs were those used by Rowe et
al. [13], except DBL4δ (1605–2039) and CIDR2β (2058–2454). All domains were cloned
into the pRE4 expression vector as described [22,23]. The pRE4 vector contains the herpes
simplex glycoprotein D signal sequence fused to the protein of interest and a transmembrane
signal sequence targeting the fusion protein to the surface of the transfected COS-7 cells
[23]. After PCR amplification and sequencing of each domain, we found several differences
in var1CSA, var2CSA and R29var1 compared to the Genbank sequences. For var1CSA,
nucleotides 1968 (G instead of A changing amino-acid I into a M), 1977(A instead of G is
silent), 4586 and 4587 (AA instead of TT changing amino-acid V into a E), between 4608
and 4609 (insertion of AAA, amino-acid K), 6970 and 6971 (AA instead of TT, changing
amino-acid L into a K) and finally nucleotide 7015 (G instead of A changing amino-acid N
into D). For var2CSA, nucleotides 204 (G instead of A) and 2082 (T instead of C) are silent
changes. In contrast nucleotides 3575 (A into G), 5182 (G into A), 5627 (G into A) and
6722 (G into A) changed amino-acids N into S, D into N, G into D and R into Q,
respectively. For R29var1, changes were in nucleotide 5849 (G into A, changing G into E)
and nucleotide 7170 (T into A, changing V into D). These modifications were confirmed by
at least two different PCR amplifications and sequencing of four different clones of each
PCR.
2.4. Transient transfection of COS-7 cells
For transfection experiments, COS-7 cells were grown overnight on 12-mm coverslips in 6-
well plates in DMEM (Invitrogen, Paisley, United Kingdom) containing 10% heat-
inactivated foetal calf serum (FCS), 2 mM glutamine, 100 U/ml penicillin and 0.1 mg/ml
streptomycin (complete DMEM). COS-7 cells were washed and transfected in antibiotic-
and serum-free DMEM with 1.5 μg DNA using “Lipofectamine reagent” (Invitrogen). After
5 h, an equal volume of antibiotic-free DMEM containing 20% FCS was added to the
transfection solution. The medium was replaced with fresh complete DMEM the following
day. To investigate whether bovine IgM might influence the results by blocking human IgM
binding, control experiments were performed using serum-free media (VP-SFM, Invitrogen)
after transfection.
2.5. Transfected COS-7 cell IgM binding and immunofluorescence assay (IFA)
IFAs were carried out as follows. Forty-eight hours after transfection, COS-7 cells were
incubated for one and a half hours at 37 °C in a medium containing 10% normal pooled
human sera. Five different lots of pooled human sera were tested, each containing serum
from at least two donors. For inhibition assays, the cells were pre-incubated for 1 h with
0.01, 0.1 or 1 mg/ml CSA before addition of human serum. Cells were washed in phosphate-
buffered saline (PBS), fixed for 10 min in PBS/2% formaldehyde and washed again in PBS.
Coverslips were incubated for 1 h either with 1D3 antibody (directed against the pRE4
glycoprotein D), [23], or with mouse monoclonal antibodies (IgG) to human IgM (Serotec,
Oxford, United Kingdom), both diluted 1:1000 in PBS/0.1% BSA. After washing for 10 min
in PBS/0.1% BSA, COS-7 cells were incubated 45 min in a 1:6000 dilution of highly cross-
absorbed Alexa Fluor™ 488 labelled goat anti-mouse IgG (Molecular Probes, Leiden, The
Netherlands). Cells were finally washed for 10 min in PBS/0.1% BSA before viewing under
the fluorescence microscope. The entire coverslips were scanned with a 20× objective to
look for positive cells, and the percentage of COS-7 cells that were positive for surface
fluorescence was counted using the 40× objective. A control experiment was performed with
secondary antibody only for each domain. Transfection efficiency and IgM binding are
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given as the percentage of positive cells using the control 1D3 antibody and the mouse anti-
human IgM antibody, respectively.
3. Results and discussion
The FCR3CSA parasite line binds to both CSA and human IgM [16]. This parasite
transcribes var1CSA at the trophozoite stage [3,20], and var2CSA at ring stage
(supplementary Fig. 1). In order to characterise the possible role of these 2 variants in IgM
binding, we tested every domain of var1CSA and var2CSA for the capacity to bind human
IgM natural antibodies. Domains of the R29var1 gene [13] were used as negative controls,
as live parasites expressing this var gene have been shown not to bind human IgM [17].
All domains of var1CSA were expressed at the surface of the COS-7 cells. Only the DBL7ε
domain showed IgM binding by IFA with a mouse mAb to human IgM, with 10–15% of the
COS-7 cells showing bright surface fluorescence (Table 1, Fig. 1A). No IgM binding was
detected with any of the other domains including the highly expressed domain DBL5γ
(Table 1, Fig. 1B). Identical results were obtained with an affinity-purified goat polyclonal
anti-human IgM reagent (Rockland, Gilbertsville, PA, USA, data not shown). For the
var2CSA gene, each domain was also expressed at the surface of the COS-7 cells. Again,
only one construct, the DBL6ε domain, gave a positive result for human IgM binding (Table
1 and Fig. 1C and D). The fluorescent signal was less intense than the signal obtained with
the construct var1CSA DBL7ε (Fig. 1A). It is unclear whether this corresponds to a real
difference between the two domains in affinity for human IgM, or merely reflects an artefact
of the in vitro expression system. With both var1CSA and var2CSA, no fluorescent signal
was detected on controls without primary antibody (Fig. 1A–D). In the control experiments
with R29var1, a PfEMP1 variant expressed by a non-IgM binding parasite [13,17], each
domain was expressed and none of them bound IgM, including the highly expressed epsilon
domain, DBL3ε (Table 1). The absence of IgM binding to the negative control R29var1
suggests that the COS cell transfection system is a reliable method for assessment of IgM
binding function.
Five different pools of serum, each composed of 2–4 donors, were used in the above
experiments, and each pool gave identical results. In addition, IgM purified from normal
human serum (Rockland, Gilbertsville, PA, USA) was tested and also bound only to
var1CSA DBL7ε and var2CSA DBL6ε, and not to any other domain.
In the 3D7 parasite clone, the var2CSA DBL6ε domain has been shown to have CSA
binding activity [15]. We therefore investigated whether CSA might inhibit IgM binding to
the FCR3 var2CSA DBL6ε. We found that IgM binding to var2CSA DBL6ε transfected
COS-7 cells was not inhibited by pre-incubation with CSA in the range 0.01–1 mg/ml. This
suggests that the binding sites for CSA and IgM are likely to be distinct, although it remains
to be confirmed that the FCR3 var2CSA DBL6ε domain tested here also has CSA binding
activity.
In a previous publication, Creasey et al. [16] demonstrated that in addition to human IgM,
some mouse IgM monoclonal antibodies were able to bind to CSA-binding infected
erythrocytes. We therefore considered the possibility that bovine IgM in the FCS used to
culture the COS-7 cells could have the potential to bind to PfEMP1 domains and interfere
with the human IgM binding assays. To test the possibility that bovine IgM might bind to
PfEMP1, we cultured FCR3CSA parasites in FCS and then carried out a live cell IFA with a
monoclonal antibody to bovine IgM. We saw faint punctuate fluorescence indicating low
level IgM binding on both uninfected and infected erythrocytes in the culture suspension,
with no evidence for increased binding to the infected erythrocytes. We therefore conclude
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that bovine IgM does not bind to PfEMP1 on infected erythrocytes, and is unlikely to
interfere with the COS-cell human IgM IFAs shown here. To further exclude the possibility
that bovine IgM might influence our results, we repeated the human IgM IFA experiments
using transfected COS-7 cells grown in serum-free media. This resulted in greatly increased
levels of background fluorescence seen with all domains (including negative controls and
mock-transfected cells). The only domains showing positive fluorescence clearly above
background levels in the serum-free medium experiments were var1CSA DBL7ε and
var2CSA DBL6ε.
It has been suggested that parasites involved in placental adhesion via non-CSA-binding
mechanisms are able to bind non-immune IgG [24]. However, CSA-binding parasites do not
bind IgG or other human Ig sub-classes [16]. In order to confirm these previous findings that
CSA-binding parasites do not bind IgG [16], we attempted to test IgG binding on both var1
and var2CSA domains expressed in COS-7 cells. Unfortunately, we found unacceptably
high background levels in the IFA for human IgG using mock transfected COS-7 cells,
therefore the COS-7 cell expression system is not suitable for studies of non-immune IgG
binding.
Our results indicate that PfEMP1 is a parasite ligand for IgM natural antibodies and show
that a single PfEMP1 molecule can bind both CSA and IgM. For both the PfEMP1 variants
studied here (var1CSA and var2CSA), the IgM binding domain was of the epsilon type and
occurred proximal to the transmembrane region. It is unclear whether the position of the
IgM binding domain is important for its function, or whether the location proximal to the
membrane in these two PfEMP1 variants is coincidental. The identification of epsilon-type
domains with IgM binding activity is in contrast to results described previously for P.
falciparum rosetting parasites, in which the CIDRα of the rosetting clone FCR3S1.2 [19]
and the DBLβ of the rosetting clone TM284S2 were identified as IgM binding domains [24].
The DBLβ domain of var1CSA was well expressed and did not bind IgM in our
experiments, however, the CIDRα domain had low expression (1% transfection efficiency),
therefore, we cannot exclude the possibility that this domain could bind IgM but we were
unable to detect it in this assay. However, careful examination of the entire coverslip in the
var1CSA CIDRα transfected cells revealed no IgM-positive cells, therefore, we think that
this is unlikely. It may be that rosetting parasites differ from CSA binding parasites in the
fine specificity of their IgM binding mechanisms, however, further data from both rosetting
and CSA binding parasites are needed before drawing any general conclusions.
We have shown that IgM natural antibodies bind a DBL epsilon domain, but IgM binding
was not seen to all the epsilon domains examined. Indeed, var1CSA has two epsilon
domains and var2CSA has three, and in each case, only one of these domains binds IgM.
The negative control R29var1 has one epsilon domain, and this did not bind IgM. Even
though all epsilon domains share some common motifs, there is still a large diversity among
these domains that can explain such differences in binding capacity. Comparison of the two
IgM binding epsilon domains with the four non-binding ones showed four small motifs
(indicated by a line) that are unique to the IgM binding domains (Fig. 2). These are SAF,
DMM, SD/EKIXKI (X being K or G) and EXRKZWW (X being N or K and Z being T or
K). Interestingly, these motifs, especially the last three, are in the central part of the domain.
Recently, Mayor et al. [25] showed that residues of DBL domains involved in red cell
invasion and cytoadherence (to CR1 and CSA) map to central regions of DBL domains. The
sequence of the 3D7 var2CSA allele shows the same motifs with only one conservative
substitution, “SAI” instead of “SAF”. Future work will characterise the role of these motifs
in a broad range of IgM natural antibody binding domains.
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Many studies on pregnancy-associated malaria are now focused on var1CSA or var2CSA as
possible vaccine candidates. Recent publications suggest that var2CSA is the most
promising candidate [14,26], however, controversy remains over the role of var1CSA [27].
In particular, it remains unclear whether the var1CSA or the var2CSA PfEMP1 variants (or
both) are expressed on the surface of CSA binding infected erythrocytes. Our previous
studies have shown that CSA binding and IgM natural antibody binding are linked
phenotypes [16], therefore, we hoped that assessment of the IgM binding capacity of the
var1CSA and var2CSA PfEMP1 variants might provide additional evidence to indicate
which of these variants is the adhesive protein on the surface of CSA binding infected cells.
Our finding that both var1CSA and var2CSA bind IgM natural antibodies does not help to
differentiate between these two vaccine candidates, and is consistent with a role for both
variants in CSA binding.
The results shown here demonstrate that CSA binding PfEMP1 variants also bind IgM
natural antibodies. The fact that CSA and IgM binding phenotypes are co-selected [16] may
indicate that natural IgM antibodies have an important role for parasite survival in the
placenta. Numerous other pathogenic micro-organisms have evolved mechanisms for
binding human immunoglobulins in order to facilitate immune evasion or invasion and
adhesion to host cells [28-34]. Strategies to block this nonimmune immunoglobulin binding
by targeting specific IgG antibodies to the pathogen's immunoglobulin-binding protein have
been suggested [32], and could be attempted for malaria parasites. Determining if IgM
natural antibodies are essential for the adhesion of the parasite in the placenta and/or for
protection from specific antibodies would be an important step in understanding their role in
the biology of the parasite during pregnancy-associated malaria. It would be of great interest
if by inhibiting IgM binding we could reduce parasite adhesion or trigger parasite clearance
by the immune system.
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CIDR cysteine-rich interdomain region
CSA chondroitin sulfate A
DBL Duffy-binding-like
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IFA immunofluorescence assay
IgM immunoglobulin M
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PfEMP1 Plasmodium falciparum erythrocyte membrane protein-1
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Immunofluorescence assay on COS-7 cells transfected with var1CSADBL7ε (A),
var1CSADBL5γ (B), var2CSADBL6ε (C), var2CSADBL1X (D). COS-7 cells were
incubated with 1D3 antibody to determine transfection efficiency (upper images), with
secondary antibody only as a negative control (middle images) or with mouse monoclonal
antibody to human IgM (lower images).
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Sequence alignment of the five, var1CSA and var2CSA, epsilon domains and R29var1
DBL3ε domain. Multiple sequence alignments were carried out using ClustalW software
available at http://www.ebi.ac.uk/clustalw/. Amino-acids specific for the two IgM binding
domains (var1CSA DBL7 and var2CSA DBL6) are shown in red, and motifs are indicated
by a line. Symbols: * indicates conserved residues;: indicates conservative substitution;.
indicates semi-conservative substitution.
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Table 1
Ability of expressed PfEMP1 domains to bind human IgM
Domain Transfection efficiency (%)a,b IgM binding (%)b,c
var1CSA
 DBL1α 2–3 0
 CIDR1α 1 0
 DBL2β 2–3 0
 DBL3γ 10–20 0
 DBL4ε 5–10 0
 DBL5γ 10–15 0
 DBL6β 3–5 0
 DBL7ε 10–20 10–15
var2CSA
 DBL1X 20–30 0
 DBL2X 10–15 0
 IDRd 1–2 0
 DBL3X 3–5 0
 DBL4ε 2–3 0
 DBL5ε 10–15 0
 DBL6ε 20–30 15–25
R29var1
 DBL1 α 20–30 0
 CIDR1γ 1–3 0
 DBL2 γ 1–3 0
 DBL3ε 20–25 0
 DBL4δ 1 0
 CIDR2β 15–20 0
a
Transfection efficiency was calculated by IFA using mAb 1D3.
b
Data from at least three experiments for each domain is shown.
c
IgM binding was determined by IFA using a mouse anti-human IgM mAb.
d
Interdomain region.
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